semaglutide & tirzepatide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Semaglutide vs Tirzepatide vs Retatrutide:

The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus

For patients experiencing skin sensitivity while taking semaglutide, several management strategies can help minimize discomfort while maintaining therapeutic benefits

Tirzepatide Tirzepatide introduced dual GIP/GLP-1 receptor activation, delivering greater weight loss than earlier GLP-1 therapies and redefining expectations for pharmacologic obesity management

Understanding GLP-1 Microdosing: A Scientific Perspective Microdosing represents a refined approach to GLP-1 therapy, utilising approximately one-tenth of standard dosing protocols, explains Dr

It is important to note that a direct, well-established causal link between GLP-1 receptor agonist use and clinically significant B12 deficiency has not been confirmed in the published literature

GLP-1 helps control appetite, balance blood sugar, reduce cravings, and support fat loss while protecting lean muscle